CRISPR Therapeutics AG (CRSP) Dips More Than Broader Market: What You Should Know
Gene Editing Therapeutics Market Report 2024, Featuring Profiles of Key Players Allogene Therapeutics, CRISPR Therapeutics, Intellia Therapeutics, Sangamo Therapeutics and Vertex Pharmaceuticals - ResearchAndMarkets.com
CRISPR Therapeutics AG (CRSP): Among the Worst ARK Stocks According to Short Sellers
CRISPR Therapeutics AG (NASDAQ:CRSP) Investors Are Less Pessimistic Than Expected
Why Is CRISPR Therapeutics (CRSP) Down 7.7% Since Last Earnings Report?
Duan Yongping followed Buffett and sold some Apple! The investment giants made big moves in the second quarter.
As for Apple, Buffett, Duan Yongping, and Bridgewater are reducing their stakes, while Jinglin, Hillhouse, and the Norwegian Sovereign Fund are increasing theirs. In general, investment giants are still somewhat wary of tech giants.